Nelson, M. H., Bowers, J. S., Bailey, S. R., Diven, M. A., Fugle, C. W., Kaiser, A. D. M., . . . Paulos, C. M. (2016). Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8(+) T cells without host preconditioning. J Immunother Cancer.
Citação norma ChicagoNelson, Michelle H., et al. "Toll-like Receptor Agonist Therapy Can Profoundly Augment the Antitumor Activity of Adoptively Transferred CD8(+) T Cells Without Host Preconditioning." J Immunother Cancer 2016.
Citação norma MLANelson, Michelle H., et al. "Toll-like Receptor Agonist Therapy Can Profoundly Augment the Antitumor Activity of Adoptively Transferred CD8(+) T Cells Without Host Preconditioning." J Immunother Cancer 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.